End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
16.3 MXN | +3.16% | +8.23% | +15.11% |
Sales 2023 | 16.47B 961M 1.3B | Sales 2024 * | 18.37B 1.07B 1.46B | Capitalization | 15.15B 884M 1.2B |
---|---|---|---|---|---|
Net income 2023 | 1.03B 60.16M 81.7M | Net income 2024 * | 2.3B 135M 183M | EV / Sales 2023 | 1.07 x |
Net Debt 2023 | 4.52B 264M 358M | Net Debt 2024 * | 1.97B 115M 156M | EV / Sales 2024 * | 0.93 x |
P/E ratio 2023 |
13.1
x | P/E ratio 2024 * |
7.41
x | Employees | 1,783 |
Yield 2023 |
1.38% | Yield 2024 * |
0.95% | Free-Float | 69.81% |
Latest transcript on Genomma Lab Internacional, S.A.B. de C.V.
1 day | +3.16% | ||
1 week | +8.23% | ||
Current month | +3.30% | ||
1 month | +4.96% | ||
3 months | +12.34% | ||
6 months | +22.46% | ||
Current year | +15.11% |
Managers | Title | Age | Since |
---|---|---|---|
Marco Sparvieri
CEO | Chief Executive Officer | - | - |
Founder | - | 96-10-29 | |
Director of Finance/CFO | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Burkhard Wittek
BRD | Director/Board Member | 70 | 18-04-17 |
Director/Board Member | - | - | |
Founder | - | 96-10-29 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.07% | 15 M€ | -1.62% | - | |
0.04% | 31 M€ | +3.50% | - | |
0.01% | 4 M€ | -4.41% | - | |
0.01% | 117 M€ | +1.11% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 16.3 | +3.16% | 4,739,936 |
24-04-25 | 15.8 | +8.29% | 6,136,163 |
24-04-24 | 14.59 | -3.25% | 4,193,193 |
24-04-23 | 15.08 | -1.76% | 2,265,864 |
24-04-22 | 15.35 | +1.93% | 3,368,367 |
End-of-day quote Mexican S.E., April 25, 2024
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+15.11% | 882M | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- LAB B Stock